SCHEMBL7058871

SCHEMBL7058871

Cc1ccnc2ccc3ccccc3c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.53
CYP2A6 P11509 4/20 0.50
TYMS P04818 2/20 0.46
TSHR P16473 5/20 0.44
MAPK1 P28482 3/20 0.44
RAB9A P51151 3/20 0.44
HSD17B10 Q99714 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HPGD P15428 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
ATM Q13315 1/20 0.44
HIF1A Q16665 1/20 0.44
CYP1A2 P05177 2/20 0.44
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 4/20 0.42
F12 P00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28123557 0.81 MAPT (0.58) CYP3A4L3MBTL1HIF1ACYP1A2CCR1
SCHEMBL5139016 0.80 CYP3A4 (0.52) CYP3A4CYP2A6TYMSTSHRMAPK1
SCHEMBL6321346 0.76 CYP3A4 (0.52) CYP3A4CYP2A6TYMSTSHRMAPK1
SCHEMBL10025807 0.76 CYP3A4 (0.61) CYP3A4CYP2A6TYMSTSHRMAPK1
SCHEMBL13169332 0.75 MAPT (0.56) CYP3A4CYP2A6MAPK1RAB9AL3MBTL1
SCHEMBL275514 0.75 CYP3A4 (0.46) CYP3A4CYP2A6TYMSMAPK1L3MBTL1
SCHEMBL8571951 0.74 CYP1A2 (0.58) CYP3A4CYP2A6TYMSTSHRMAPK1
SCHEMBL17532752 0.74 TYMS (0.46) CYP3A4CYP2A6TYMSTSHRMAPK1
SCHEMBL460290 0.74 GPR3 (0.57) CYP2A6RAB9ACYP1A2ALDH1A1NPC1
SCHEMBL28864050 0.73 CYP3A4 (0.74) CYP3A4CYP2A6TYMSTSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133645-A1 RADIOLABELED COMPOUNDS FOR IMAGING OF FIBROBLAST ACTIVATION PROTEIN (FAP) AND TREATMENT OF FAP-RELATED DISORDERS PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2023-07-20 WO disclosed
WO-2003026657-A1 COMPOUNDS FOR THE TREATMENT OF PAIN SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-04-03 WO disclosed